Galena Biopharma
  • About Us
    • Leadership
    • Career Opportunities
  • Products
    • Abstral®
  • Clinical Development
    • Pipeline
    • Clinical Trials
    • NeuVax™ (nelipepimut-S)
    • FBP (E39)
    • Technology
  • Business Development
  • Investors
    • Stock Information
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Email Alerts
    • Corporate Governance
    • Analyst Coverage
  • News
  • Resources
Discovery. Delivery. Development. Technology

Galena Biopharma develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.

Click to Learn How NeuVax Works
Click to View the Latest Galena Biopharmaceuticals Comany Presentation
Click to View the Latest Galena Biopharmaceuticals Shareholder Letter
Click to View the Latest Galena Biopharmaceuticals Annual Report

Galena Biopharma in the News

Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting

VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results

William L. Ashton Joins Galena Biopharma's Board of Directors

Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference

More news
Email Print
  • Home
  • Legal
  • LinkedIn
  • Galena Biopharma. All rights reserved.
info@galenabiopharma.com
1-855-855-GALE
310 N. State Street, Suite 208 | Lake Oswego, OR 97034